Article Text

PDF

Flow cytometric diagnostic assessment of cell-derived microparticles is severely confounded by immune complexes in rheumatoid arthritis
  1. Bence György1,
  2. Károly Módos2,
  3. Éva Pállinger1,
  4. Krisztina Pálóczi1,
  5. Mária Pásztói1,3,
  6. Petra Misják1,
  7. Mária A Deli4,
  8. áron Sipos5,
  9. Anikó Szalai5,
  10. István Voszka2,
  11. Anna Polgár6,
  12. Kálmán Tóth7,
  13. Mária Csete5,
  14. György Nagy1,8,
  15. Steffen Gay9,
  16. András Falus1,3,
  17. ágnes Kittel10,
  18. Edit I Buzás1
  1. 1Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
  2. 2Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary
  3. 3Research Group for Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences, Budapest, Hungary
  4. 4Laboratory of Molecular Neurobiology, Institute of Biophysics, Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary
  5. 5Department of Optics and Quantum Electronics, University of Szeged, Szeged, Hungary
  6. 6National Institute of Rheumatology and Physiotherapy, Budapest, Hungary
  7. 7Department of Orthopaedics, University of Szeged, Szeged, Hungary
  8. 8Department of Rheumatology, Semmelweis University, Budapest, Hungary
  9. 9Center for Experimental Rheumatology, Zürich Center for Integrative Human Physiology, USZ, Zürich, Switzerland
  10. 10Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary

Abstract

Background and objectives Microparticles/microvesicles are readily detectable in various biological fluids, and have recently been shown to be highly specific and sensitive biomarkers, for example, in tumours. Numerous autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis, have also been reported to associate with elevated microparticle counts. On the other hand, the above autoimmune diseases have long been known to be characterised by accelerated immune complex formation as well. The goal of this study was to investigate the potential overlap between biophysical parameters of immune complexes and microparticles, which might perturb detection and/or isolation of microparticles.

Materials and methods We analysed microparticles from blood plasma of healthy individuals (n=12) and rheumatoid arthritis patients (n=12). Furthermore we also examined synovial fluid-derived microparticles from rheumatoid arthritis and osteoarthritis patients (n=11, respectively). Microparticles, as well as artificial and synovial fluid-derived immune complexes were characterised by using electron microscopy, atomic force microscopy, dynamic light scattering analysis and flow cytometry.

Results The used methods gave concordant results regarding the size distribution of the preparations. Very importantly, we found a significant size overlap between microparticles and immune complexes. As a consequence, immune complexes gave robust signals on flow cytometry within the conventional microparticle gate. This, in turn, affected microparticle quantification by flow cytometry in rheumatoid arthritis, where the immune complex content was high compared to osteoarthritis samples. We developed a novel method to differentiate between microparticles and immune complexes in flow cytometry. Using this method, we found that in rheumatoid arthritis, the total event count within the microparticle gate (earlier considered as microparticle count) was highly proportional with the amount of immune complexes, but did not correlate with microparticle count. Furthermore, immune complexes were found in the conventionally isolated microparticle pellets.

Conclusions For the first time, we drive attention to the fact that the presence of immune complexes in patient samples has significant impact on microparticle detection and isolation. These findings have general implications in diseases, where immune complex formation is common, including not only autoimmune diseases, but also haematological disorders, infections and cancer. These data may necessitate re-evaluation of certain published data on patient-derived microparticles, and contribute to correct the clinical laboratory assessment of the presence and biological functions of microparticles in health and disease.1

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.